List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global External Neuromodulation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Transcutaneous Electrical Nerve Stimulation
1.2.3 Transcranial Magnetic Stimulation
1.2.4 Respiratory Electrical Stimulation
1.3 Market by Application
1.3.1 Global External Neuromodulation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2017-2028)
2.2 External Neuromodulation Growth Trends by Region
2.2.1 External Neuromodulation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 External Neuromodulation Historic Market Size by Region (2017-2022)
2.2.3 External Neuromodulation Forecasted Market Size by Region (2023-2028)
2.3 External Neuromodulation Market Dynamics
2.3.1 External Neuromodulation Industry Trends
2.3.2 External Neuromodulation Market Drivers
2.3.3 External Neuromodulation Market Challenges
2.3.4 External Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Revenue
3.1.1 Global Top External Neuromodulation Players by Revenue (2017-2022)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2017-2022)
3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by External Neuromodulation Revenue
3.4 Global External Neuromodulation Market Concentration Ratio
3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2021
3.5 External Neuromodulation Key Players Head office and Area Served
3.6 Key Players External Neuromodulation Product Solution and Service
3.7 Date of Enter into External Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 External Neuromodulation Breakdown Data by Type
4.1 Global External Neuromodulation Historic Market Size by Type (2017-2022)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2023-2028)
5 External Neuromodulation Breakdown Data by Application
5.1 Global External Neuromodulation Historic Market Size by Application (2017-2022)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America External Neuromodulation Market Size (2017-2028)
6.2 North America External Neuromodulation Market Size by Type
6.2.1 North America External Neuromodulation Market Size by Type (2017-2022)
6.2.2 North America External Neuromodulation Market Size by Type (2023-2028)
6.2.3 North America External Neuromodulation Market Share by Type (2017-2028)
6.3 North America External Neuromodulation Market Size by Application
6.3.1 North America External Neuromodulation Market Size by Application (2017-2022)
6.3.2 North America External Neuromodulation Market Size by Application (2023-2028)
6.3.3 North America External Neuromodulation Market Share by Application (2017-2028)
6.4 North America External Neuromodulation Market Size by Country
6.4.1 North America External Neuromodulation Market Size by Country (2017-2022)
6.4.2 North America External Neuromodulation Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe External Neuromodulation Market Size (2017-2028)
7.2 Europe External Neuromodulation Market Size by Type
7.2.1 Europe External Neuromodulation Market Size by Type (2017-2022)
7.2.2 Europe External Neuromodulation Market Size by Type (2023-2028)
7.2.3 Europe External Neuromodulation Market Share by Type (2017-2028)
7.3 Europe External Neuromodulation Market Size by Application
7.3.1 Europe External Neuromodulation Market Size by Application (2017-2022)
7.3.2 Europe External Neuromodulation Market Size by Application (2023-2028)
7.3.3 Europe External Neuromodulation Market Share by Application (2017-2028)
7.4 Europe External Neuromodulation Market Size by Country
7.4.1 Europe External Neuromodulation Market Size by Country (2017-2022)
7.4.2 Europe External Neuromodulation Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific External Neuromodulation Market Size (2017-2028)
8.2 Asia-Pacific External Neuromodulation Market Size by Type
8.2.1 Asia-Pacific External Neuromodulation Market Size by Type (2017-2022)
8.2.2 Asia-Pacific External Neuromodulation Market Size by Type (2023-2028)
8.2.3 Asia-Pacific External Neuromodulation Market Share by Type (2017-2028)
8.3 Asia-Pacific External Neuromodulation Market Size by Application
8.3.1 Asia-Pacific External Neuromodulation Market Size by Application (2017-2022)
8.3.2 Asia-Pacific External Neuromodulation Market Size by Application (2023-2028)
8.3.3 Asia-Pacific External Neuromodulation Market Share by Application (2017-2028)
8.4 Asia-Pacific External Neuromodulation Market Size by Region
8.4.1 Asia-Pacific External Neuromodulation Market Size by Region (2017-2022)
8.4.2 Asia-Pacific External Neuromodulation Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America External Neuromodulation Market Size (2017-2028)
9.2 Latin America External Neuromodulation Market Size by Type
9.2.1 Latin America External Neuromodulation Market Size by Type (2017-2022)
9.2.2 Latin America External Neuromodulation Market Size by Type (2023-2028)
9.2.3 Latin America External Neuromodulation Market Share by Type (2017-2028)
9.3 Latin America External Neuromodulation Market Size by Application
9.3.1 Latin America External Neuromodulation Market Size by Application (2017-2022)
9.3.2 Latin America External Neuromodulation Market Size by Application (2023-2028)
9.3.3 Latin America External Neuromodulation Market Share by Application (2017-2028)
9.4 Latin America External Neuromodulation Market Size by Country
9.4.1 Latin America External Neuromodulation Market Size by Country (2017-2022)
9.4.2 Latin America External Neuromodulation Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa External Neuromodulation Market Size (2017-2028)
10.2 Middle East & Africa External Neuromodulation Market Size by Type
10.2.1 Middle East & Africa External Neuromodulation Market Size by Type (2017-2022)
10.2.2 Middle East & Africa External Neuromodulation Market Size by Type (2023-2028)
10.2.3 Middle East & Africa External Neuromodulation Market Share by Type (2017-2028)
10.3 Middle East & Africa External Neuromodulation Market Size by Application
10.3.1 Middle East & Africa External Neuromodulation Market Size by Application (2017-2022)
10.3.2 Middle East & Africa External Neuromodulation Market Size by Application (2023-2028)
10.3.3 Middle East & Africa External Neuromodulation Market Share by Application (2017-2028)
10.4 Middle East & Africa External Neuromodulation Market Size by Country
10.4.1 Middle East & Africa External Neuromodulation Market Size by Country (2017-2022)
10.4.2 Middle East & Africa External Neuromodulation Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Details
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.1.5 Medtronic, Inc. (US) Recent Developments
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Details
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.2.5 Boston Scientific Corporation (US) Recent Developments
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Details
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.3.5 St. Jude Medical, Inc. (US) Recent Developments
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Details
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.4.5 Synapse Biomedical, Inc. (US) Recent Developments
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Details
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) External Neuromodulation Introduction
11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.5.5 Nevro Corporation (US) Recent Developments
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Details
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.6.5 Neurosigma, Inc. (US) Recent Developments
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Details
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.7.5 Neuropace, Inc. (US) Recent Developments
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Details
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.8.5 Neuronetics, Inc. (US) Recent Developments
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Details
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.9.5 Cyberonics, Inc. (US) Recent Developments
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Details
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2017-2022)
11.10.5 BioControl Medical (Israel) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
